defibrillator Market

The defibrillator market is projected to reach US$ 14,876.95 million by 2028 from US$ 10,478.31 million in 2021. It is estimated to grow at a CAGR of 5.1% % from 2021 to 2028.

Defibrillators are medical devices used to administer a high-energy shock to the heart of a patient experiencing cardiac arrest. The growing prevalence and incidence of cardiovascular diseases (CVDs) have increased the risk of cardiac dysrhythmias, such as ventricular fibrillation (VF) and non-perfusing ventricular tachycardia (VT), which can be effectively treated using defibrillators. There are two types of defibrillators: external and implantable. External defibrillators come in various forms, including manual, automated, and wearable, while implantable defibrillators are typically placed on or inside the patient and can be either transvenous implantable cardioverter defibrillators (ICDs) or subcutaneous ICDs.  

MARKET DYNAMICS

The increasing prevalence of cardiovascular disorders is one of the key factors driving the defibrillator market. With the rising incidence of heart-related diseases, the demand for defibrillators has increased as they are essential for saving the lives of patients who experience sudden cardiac arrest. This has led to an increase in the production and distribution of defibrillators. Furthermore, there has been a surge in training and awareness programs on cardiopulmonary resuscitation (CPR) and the use of automated external defibrillators (AEDs). These programs aim to educate people on how to respond to sudden cardiac arrest and use defibrillators in emergency situations. As a result, more people are being trained to use defibrillators, and there is an increased demand for defibrillators in public places such as airports, shopping malls, and sports arenas.  The market growth may be hindered by issues related to cost and performance of implantable and automated external defibrillators.

MARKET SEGMENTATION

The defibrillator market is categorized by product type, with two segments: implantable cardioverter defibrillator and external defibrillator. the implantable cardioverter defibrillator segment is divided into transverse icd and subcutaneous icd, while the external defibrillator segment is further divided into fully automated external defibrillators, manual, and wearable. In 2021, the implantable cardioverter defibrillator segment is anticipated to have the largest market share of 68.80%. Firstly, ICDs are considered to be the most effective treatment for patients at high risk of sudden cardiac arrest. They are implanted under the skin in the chest and are capable of detecting and treating life-threatening heart arrhythmias. As a result, ICDs are an important medical device for patients who have experienced or are at risk of cardiac arrest. Secondly, technological advancements have led to the development of newer and more advanced ICDs, such as the subcutaneous ICD (S-ICD) and transvenous ICD (TV-ICD), which offer improved performance, greater patient comfort, and reduced risk of complications. Lastly, the rising prevalence of cardiovascular diseases and the aging population have contributed to the growth of the ICD market. As the number of patients at risk of sudden cardiac arrest increases, the demand for ICDs is expected to rise as well. Based on the end user, the market is segmented into Hospitals and Clinics, Prehospital Care, Public Access, Home Care Settings, and Alternate Care Facilities. The Hospitals and Clinics segment is expected to have a larger market share in 2021, while the Prehospital Care segment is projected to show a higher CAGR during the forecast period.

National Center for Chronic Disease Prevention and Health Promotion, World Health Organization, Australian Bureau of Statistics are among the primary and secondary sources referred to while preparing the defibrillator market report.